➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Colorcon
Harvard Business School
McKesson
Merck

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,101,569


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,101,569 protect, and when does it expire?

Patent 7,101,569 protects LEVOXYL and is included in one NDA.

This patent has twenty-six patent family members in nine countries.

Summary for Patent: 7,101,569
Title:Methods of administering levothyroxine pharmaceutical compositions
Abstract:The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
Inventor(s): Franz; G. Andrew (St. Louis, MO), Strauss; Elaine A. (Seminole, FL), DiMenna; Phillip A. (St. Petersburg, FL), Gemma; Rocco L. (Dover, OH)
Assignee:
Application Number:10/218,718
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 7,101,569

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-001 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-002 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-003 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-004 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-005 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-006 May 25, 2001 AB1,AB3 RX Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF USE OF ADMINISTERING LEVOTHYROXINE ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,101,569

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2002240394 ⤷  Try it Free
Australia 2002258397 ⤷  Try it Free
Australia 2002332507 ⤷  Try it Free
Australia 2002341555 ⤷  Try it Free
Australia 2002362468 ⤷  Try it Free
Brazil 0207297 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
McKinsey
McKesson
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.